The aim of the present research work is to explore the application of mixed solvency concept to formulate and develop a fast dissolving oral film of furosemide with improved drug loading. In the present study, poorly soluble drug, furosemide was tried to be solubilized by employing the combination of physiologically compatible water-soluble additives (solubilizers) to formulate its fast dissolving formulations. For the development of fast dissolving oral film, firstly, different film forming polymers were tested for their film properties. The second fast dissolving layer was also formed and optimized. Solubility studies were conducted to select water-soluble additives for formulation of fast dissolving drug layer. Keeping the total concentration less than 40 % w/v of mixed blends, different aqueous blends were prepared employing solubilizers from among sodium benzoate, sodium acetate, sodium citrate, urea, niacinamide, glycerin, propylene glycol, polyethylene glycol 200, polyethylene glycol 400, polyethylene glycol 600, and PVP K 30. Maximum solubility of furosemide was found in blends-F5 (10% sodium caprylate +2.5%sodium benzoate+ 2.5% niacinamide) and in blend F7 (10% sodium caprylate +2.5%sodium benzoate +2.5% sodium citrate + 2.5% niacinamide). Prepared films were evaluated for drug content, thickness, folding endurance, tensile strength and hydration ratio. 
INTRODUCTION
Oral drug delivery is the most widely acceptable drug delivery system as it provides numerous advantages when compared to other drug delivery systems. But due to some limitations like lesser bioavailability of drug, longer onset time and dysphagia patients, manufacturers bend towards parenteral and liquid orals. Whereas liquid orals having the problem associated with accurate dosing and also painful for parenteral drug administration, which creates patient incompliance. There are three important factors for any drug product viz bioavailability, quicker action (if required) and patient compliance. So, each company wants to formulate the products which fulfils these three factors according to the patient's need to increase their market profile [1] . To provide maximum concentration at the site of action of drug and achieve therapeutic level and to maintain it is main aim of any drug delivery system.
Fast dissolving oral film (FDF)
This novel drug delivery system was introduced as a substitute for conventional oral dosage forms for patients who cannot swallow medicines easily, bed-prone patients, geriatric patients and pediatric patients. Orally disintegrating tablets are present in the market which gives disintegrating time of one to two minutes. Mouth dissolving films were then introduced which significantly marked an upgradation in the oral disintegrating drug delivery system. The various avenues explored for rapid drug releasing product, mouth dissolving film method is gaining much attention. [2] Recently, the regulatory authorities have enlarged the variety of "oro mucosal preparations" by buccal films and oro dispersible films. The United States Food and Drug Administration (USFDA) use the term 'soluble film' for mouth dissolving films. The European Pharmacopoeia (Ph.Eur.) monograph on oro mucosal preparations was updated in its 7.4 edition, including 'mucoadhesive preparation' and 'fast dissolving film'. Mouth dissolving films are described in the monograph as rapidly dispersing single or multilayer sheets of suitable material. [3] Mouth dissolving films contain active molecules which are dissolved or dispersed in the film, the film is placed on a tongue of patient where it gets disintegrated and dissolves to release the drug for absorption. The problem of drug administration of certain groups of patients like paediatrics, geriatric, bedridden, nauseous or noncompliant patients, and scientists developed new dosage alternatives from oral route to keep these patients' group in mind and mouth-dissolving film is one of the alternative dosage forms of oral route.
Drug release mechanism of FDF
The mouth dissolving oral film is a very thin film placed on tongue, gets instantly wetted by saliva, disintegrates and dissolves rapidly to release drug. This released drug gets absorbed directly in to the systemic circulation by oral mucosa. Oral mucosal drug delivery is a potential site for drug administration. It provides rapid onset of action, enhanced bioavailability of drug and by passes presystemic elimination within GI tract. Oral mucosa is highly permeable and rich in blood supply, so the drug is directly absorbed into the blood circulation. 
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Mixed Solvency Concept
Maheshwari [6] proposed the concept of mixed-solvency concept and proved that all substances whether liquids, solids or gases may enhance the solubility of poorly-soluble drugs. He has carried out solubility studies on poorly-water soluble drug, salicylic acid (as model drug). Solubility studies were carried in the solutions containing hydrotropic agents (urea and sodium citrate), cosolvents (glycerin, propylene glycol, PEG 300 and PEG 400) and water-soluble solids (PEG 4000 and PEG 6000) individually as well as in 10 randomly prepared blends keeping total concentration constant i.e. 40%. Results showed that seven out of ten blends produced synergistic effect on solubility enhancement.
Several studies have been conducted on various poorly soluble drugs using mixed solvency concept.
MATERIALS AND METHOD
Materials
Furosemide drug was obtained as a gift sample from IPCA Laboratories, Pithumpur. Other chemicals used were of analytical grade. Demineralized water was used in the study.
Method Preparation of aqueous solutions of solubilizers
For the preparation of different blends of solubilizers (% w/v), sodium caprylate, niacinamide, sodium citrate, caffeine, PVP k 30, propylene glycol, PEG 200, PEG 400, PEG 600, glycerin etc. were weighed/ measured and taken in a volumetric flask and about 50 ml of DM water was added in this flask and was shaken to achieve complete dissolution of solubilizers. Then, volume was made up to 100 ml by DM water. Total solute concentration was varied up to 40% w/v concentration and the % solubility of drug (furosemide) was calculated.
Solubility studies:
Solubility studies in different aqueous systems of solubilizers were carried out by equilibrium solubility method.
According to this method, 5 ml of respective medium was taken in a vial and excess amount of drug furosemide was added in above vial, kept it closed by rubber cap with aluminium seal, and was placed on a mechanical shaker at room temperature for 12 hours, and solution was allowed to equilibrate for 24 hours undisturbed. Then, the solution was filtered through filter paper. The filtrate was appropriately diluted with the respective aqueous medium and the absorbance of the solution was measured at 333 nm on a double beam UV/Visible spectrophotometer (Shimadzu 1700) against respective reagent blanks. The percent solubility was calculated using calibration curves. Because of excess solubility, semi solid mass was produced and it could not be filtered to determine the solubility
Solubility of furosemide in different medium
Because of excess solubility, semi solid mass was produced and it could not be filtered to determine the solubility ---
Here-SC-Sodium caprylate, NM-Niacinamide, SB-Sodium benzoate, SCI-sodium citrate, SA-Sodium acetate
Selection of polymers
For selection of water-soluble film forming polymers, films of different polymers were prepared and their film properties were evaluated. As the important function of polymer was to provide mechanical strength and quick disintegration to the film, its selection was done taking physical strength and disintegration as the most important optimization parameters of the film. For preparation of polymer films, 8.5 ml of blend containing 15% v/v glycerin (as plasticizer) was taken in a vial. Polymer (1.5 gm) was added and made up to 10 ml with blend, preparation was stirred properly and placed undisturbed for 5-6 hrs. The film of resulting polymer solution was casted in petri plate and was dried at 40ºC in hot air oven for 24 hours and then wrapped in aluminium foil and stored. The prepared films were evaluated for their film properties.
Evaluation of casted polymeric film a) Disintegration time
Disintegration was tested by taking 25 ml of phosphate buffer (pH 6.8) in a Petri dish and a film was placed in it.
Swirling of the buffer was done manually in every 10 seconds. Time required to completely break and disperse the film was noted as the disintegration time.
b) Folding endurance
Folding endurance was determined by repeatedly folding the film at the same position until it breaks. The number of times the films can be folded without breaking is termed as the folding endurance value.
c) Thickness
The thickness of film was determined by the use of micrometre (Digimatic micrometre, Mitutoyo, Tokyo, Japan) at five locations (centre and four corners) and mean thickness was calculated. 
Optimization of concentration of polymer
Five batches of different selected polymer (HPMC E-5) concentrations were prepared, casted and their film properties were studied. 
Selection of plasticizer
The effect of glycerine, propylene glycol, polyethylene glycol as plasticizer was studied. Five batches of HPMC E-5 films were prepared with respective plasticizers used in concentration of 15% v/v and properties of casted films were evaluated. 
Optimization of plasticizer concentration
Five batches of HPMC E-5 with different concentration range 5%-25% of selected plasticizer (Glycerine) were prepared and their film properties were studied. 
Selection of super disintegrants
Solutions of four different polymeric formulations of HPMC E-5 (15% w/v) were prepared with (15% v/v) glycerin and in each of this solution respective super disintegrant (0.3%w/v) was added and films were casted in Petri plates, after proper drying at 40°C for 24 hours then films were wrapped in aluminium foil with sealing plastic bags, stored and their film properties were studied. 
Optimization of super disintegrant concentration
Solutions of four different polymeric formulations of HPMC E-5 (15% w/v) were prepared with (15% v/v) glycerine and in each of this solution cross povidone in different concentration range 0.3%-0.6% w/v were added in preparation and films were casted in Petri plate, after proper drying at 40°C for 24 hours then film were wrapped in aluminium foil with sealing plastic bags, stored and their film properties were studied. 
Formulation of FDF of furosemide
According to the preliminary studies and studies of selection of excipients, for the preparation and optimization of fast dissolving film layer, 8 batches were designed and fast dissolving films of different 8 formulae (table 31) were prepared (on the basis of less individual concentration of solubilizers and greater solubility enhancement of drug.) 
Evaluation studies of fabricated FDF a) In vitro dissolution rate study
Films containing 20 mg of furosemide were used in the in vitro dissolution study. Dissolution studies were conducted in USP II apparatus (paddle type) at 50 rpm, using 900 ml of 0.1 N HCl and 300 ml of simulated saliva fluid (2.38 gm Na2HPO4, 0.19 gm KH2PO4, and 8.00 gm NaCl per litre of distilled water adjusted with phosphoric acid to pH 6.8) as dissolution media. The temperature was maintained at 37±0.5˚ C. Ten ml samples were withdrawn at regular intervals and analyzed spectrophotometrically (Shimadzu A-160) at 333 nm after appropriate dilution with 0.1 N HCl and simulated saliva fluid respectively. Absorbances were noted against respective reagent blanks (placebo). An equal amount of fresh dissolution media was replaced immediately after each withdrawal of sample.
b) % Drug content determination
It was determined by taking one film theoretically equivalent to 20mg of drug and transferred in 1000 ml volumetric flask and approximately 400 ml of DM water was added to it. Flask was shaken for 15 minutes and volume was made up to the mark with DM water. The resulting solution was filtered and analyzed spectrophotometrically at 333 nm and drug content was determined.
% drug content= (practical value/ theoretical value) × 100 c) Surface pH Film was taken and placed in a Petri plate containing 5 ml of water. After wetting of the film, the surface pH of the film was checked by using pH electrode.
d) Thickness
The thickness of film was determined by the use of micrometre (Digimatic micrometre, Mitutoyo, Tokyo, Japan) at five locations (centre and four corners) and mean thickness was calculated. In vitro dissolution rate study-Films containing 20 mg of furosemide were used in the in vitro dissolution study. Dissolution studies were conducted in USP II apparatus (paddle type) at 50 rpm, using 900 ml of 0.1 N HCl and 300 ml of simulated saliva fluid (2.38 gm Na2HPO4, 0.19 gm KH2PO4, and 8.00 gm NaCl per litre of distilled water adjusted with phosphoric acid to pH 6.8) as dissolution media. The temperature was maintained at 37±0.5˚ C. Ten ml samples were withdrawn at regular intervals and analysed spectrophotometrically (Simadzu A-160) at 333 nm after appropriate dilution with 0.1 N HCl and simulated saliva fluid respectively. Absorbance was noted against respective reagent blanks (placebo). An equal amount of fresh dissolution media was replaced immediately after each withdrawal of sample. Stability study of optimized film formulation was carried out for two months at room temperature and refrigerated temperature. 
RESULTS AND DISCUSSION
For the selection of solubilizers for increasing the solubility of drug (furosemide), solubility studies were conducted at room temperature in various solutions containing individual solubilizer or in combination of solubilizers blend. The solubility of furosemide was increased up to 11.52 % (w/v) in solubilizer in Blend F5 (10% sodium caprylate +2.5%sodium benzoate+ 2.5% niacinamide) and in Blend F7 (10% sodium caprylate +2.5%sodium benzoate +2.5% sodium citrate + 2.5% niacinamide) up to 12.43 % (w/v) that was maximum among all the blends. In order to minimize the probable toxic effects of individual solubilizer at high concentration, the blends of solubilizers were tried to give the expected solubility. The blends of solubilizers of total strength 15% and 17.5% w/v were used in selected final blends to get sufficiently expected solubilities. The maximum synergistic effect was observed in the blend containing sodium caprylate, sodium benzoate, niacinamide, sodium acetate, sodium citrate.
For the development of fast dissolving film, different film forming polymers, plasticizers, super disintegrants were tested. According to the mechanical properties and disintegration time of film, they were selected and optimized. HPMC E-5 15% w/v was taken as optimized concentration of polymer. On the basis of film properties, 15% v/v concentration of glycerine (as plasticizer) was optimized and selected. Crosspovidone in concentration of 0.4% w/v was optimized because of desired thickness and desired disintegration time (< 30 sec).
From selected and optimized ingredients, eight batches of fast dissolving film containing 20 mg dose of drug per 4 cm² were developed and evaluated for thickness, folding endurance, disintegration time and in-vitro dissolution profile. Amongst all the batches, FD5 and FD7 batch of prepared fast dissolving films showed better in vitro dissolution profile, disintegration time and were selected for stability studies. They were found quiet stable for 2 months.
CONCLUSION
From all the above studies, it was concluded that the approach of mixed solvency is novel, safe, cost-effective and user friendly. It also eliminates the problem of toxicity associated with high concentration of single solubilizers. So, it may be employed in dosage form development of drugs where fast onset of action is desired. It may also enhance the bioavailability associated with poor dissolution of drug.
